Key result
Weight fluctuation did not significantly increase the risk of metabolic syndrome in either normal-weight (HR 1.01) or obese (HR 1.00) individuals over a 16-year follow-up.
Why the study?
Frequent weight fluctuation is common with dieting, but its health risks for metabolic syndrome remain a public health concern.
Does weight fluctuation increase the risk of metabolic syndrome in Korean adults?
Cohort (n=8,150)
Yes
Does weight fluctuation increase the risk of metabolic syndrome in Korean adults?
Long-term weight fluctuation does not increase the overall risk of metabolic syndrome, but is an independent risk factor for abdominal obesity in normal-weight individuals.
Answers are grounded in this paper and cite their sources.
WF was not tied to higher MS risk; leaves open abdominal obesity links in normal-weight adults.
BACKGROUND: Weight fluctuation (WF) is highly prevalent in parallel with the high prevalence of intentional or unintentional dieting. The health risks of frequent WF for metabolic syndrome (MS) have become a public health concern, especially for health care providers who supervise dieting as an intervention to prevent obesity-related morbidity or to improve health, as well as for the general population for whom dieting is of interest. The aim of this study was to investigate the long-term effect of WF on the risk of MS in Koreans. METHODS: This study analyzed secondary data from the Korean Genome and Epidemiology Study, a 16-year prospective cohort study, on 8150 individuals using time-dependent Cox regression. RESULTS: WF did not increase the risk of MS in either normal-weight or obese subjects. In an analysis of the components of MS, greater WF significantly increased the risk of abdominal obesity (HR = 1.05, 95% CI = 1.02-1.07, p < 0.001) in normal-weight individuals. However, WF did not increase the risk of hyperglycemia, low high-density lipoprotein cholesterol levels, elevated blood pressure, or raised fasting glucose in normal-weight individuals, and it did not influence any of the components of MS in obese individuals. CONCLUSION: Since WF was found to be a risk factor for abdominal obesity, which is the most reliable predictor of MS, it should be considered when addressing weight control. Further studies on cut-off points for the degree of weight loss in a certain period need to be conducted to help clinicians provide guidance on appropriate weight control.
No takes yet. Share an insight, caveat, or question.
Chin et al. (2021) conducted a cohort in Metabolic syndrome (n=8,150). Weight fluctuation vs. Lower weight fluctuation was evaluated on Incident metabolic syndrome (normal-weight group) (HR 1.01, 95% CI 0.98-1.04, p=0.569). Weight fluctuation did not significantly increase the risk of metabolic syndrome in either normal-weight (HR 1.01) or obese (HR 1.00) individuals over a 16-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: